Cargando…
2′-O-Methylperlatolic Acid Enhances Insulin-Regulated Blood Glucose-Lowering Effect through Insulin Receptor Signaling Pathway
PURPOSE: Insulin receptor (InsR) sensitizers represent a new type of therapeutic agent for the treatment of diabetes, with 2′-O-methylperlatolic acid (2-O-M) being a potential InsR targeting drug. The purpose of this study was to determine whether 2-O-M functions as an activator of the insulin signa...
Autores principales: | Yinghao, Wang, Qiaoli, Guan, Guanfu, Liu, Xiaoyun, Wu, Xuanjun, Wang, Jun, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056246/ https://www.ncbi.nlm.nih.gov/pubmed/35502441 http://dx.doi.org/10.1155/2022/2042273 |
Ejemplares similares
-
Serpentine Enhances Insulin Regulation of Blood Glucose through Insulin Receptor Signaling Pathway
por: Wang, Yinghao, et al.
Publicado: (2022) -
Potentiation of Insulin-Mediated Glucose Lowering without Elevated Hypoglycemia Risk by a Small Molecule Insulin Receptor Modulator
por: Wu, Margaret, et al.
Publicado: (2015) -
Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
por: Konstantopoulos, Nicky, et al.
Publicado: (2012) -
Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice
por: Kaur, Gurvinder, et al.
Publicado: (2018) -
Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice
por: Lee, H Y, et al.
Publicado: (2008)